Computed tomography coronary plaque imaging as a secondary end point for randomized pharmaceutical trials: more bang for the buck?
- PMID: 20484111
- DOI: 10.1161/CIRCIMAGING.110.957316
Computed tomography coronary plaque imaging as a secondary end point for randomized pharmaceutical trials: more bang for the buck?
Comment on
-
Treatment with 5-lipoxygenase inhibitor VIA-2291 (Atreleuton) in patients with recent acute coronary syndrome.Circ Cardiovasc Imaging. 2010 May;3(3):298-307. doi: 10.1161/CIRCIMAGING.110.937169. Epub 2010 Feb 27. Circ Cardiovasc Imaging. 2010. PMID: 20190281 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical